{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:58:54Z","timestamp":1777352334823,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI100138"],"award-info":[{"award-number":["R01 AI100138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2016.12.035","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T02:10:42Z","timestamp":1483755042000},"page":"1080-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Sudeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Sunagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund J.","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6673","key":"10.1016\/j.vaccine.2016.12.035_b0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.12.035_b0010","doi-asserted-by":"crossref","first-page":"869718","DOI":"10.1155\/2013\/869718","article-title":"Targeting antigens to dendritic cell receptors for vaccine development","volume":"2013","author":"Apostolopoulos","year":"2013","journal-title":"J Drug Delivery"},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.035_b0015","doi-asserted-by":"crossref","DOI":"10.4161\/hv.25876","article-title":"Dendritic cell based vaccines for HIV infection: the way ahead","volume":"9","author":"Garcia","year":"2013","journal-title":"Human Vaccines Immunotherapeutics"},{"issue":"7","key":"10.1016\/j.vaccine.2016.12.035_b0020","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI67550","article-title":"Antigen-activated dendritic cells ameliorate influenza A infections","volume":"123","author":"Boonnak","year":"2013","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.035_b0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri2173","article-title":"Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting","volume":"7","author":"Tacken","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.035_b0030","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.4049\/jimmunol.0900364","article-title":"Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice","volume":"183","author":"Gil","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.035_b0035","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.188.5.809","article-title":"Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae","volume":"188","author":"Su","year":"1998","journal-title":"J Exp Med"},{"issue":"166","key":"10.1016\/j.vaccine.2016.12.035_b0040","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.035_b0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2008-0446OC","article-title":"Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen","volume":"41","author":"Ozawa","year":"2009","journal-title":"Am J Respiratory Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.035_b0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2567.2012.03590.x","article-title":"Dendritic cell-based immunity and vaccination against hepatitis C virus infection","volume":"136","author":"Zhou","year":"2012","journal-title":"Immunology"},{"issue":"7543","key":"10.1016\/j.vaccine.2016.12.035_b0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature14320","article-title":"Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients","volume":"519","author":"Mitchell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.12.035_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.trsl.2015.07.008","article-title":"Antitumor dendritic cell-based vaccines: lessons from 20years of clinical trials and future perspectives","volume":"168","author":"Constantino","year":"2016","journal-title":"Transl Res: J Lab Clin Med"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.035_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.035_b0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11912-011-0152-5","article-title":"Sipuleucel-T: prototype for development of anti-tumor vaccines","volume":"13","author":"Carballido","year":"2011","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2016.12.035_b0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrmicro1045","article-title":"Tularaemia: bioterrorism defence renews interest in Francisella tularensis","volume":"2","author":"Oyston","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.035_b0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.035_b0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000441-199408000-00003","article-title":"Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine","volume":"308","author":"Drabick","year":"1994","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.035_b0090","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.4049\/jimmunol.0803242","article-title":"Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis","volume":"182","author":"Bitsaktsis","year":"2009","journal-title":"J Immunol"},{"issue":"40","key":"10.1016\/j.vaccine.2016.12.035_b0095","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.vaccine.2014.07.050","article-title":"Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells","volume":"32","author":"Pham","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.035_b0100","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4049\/jimmunol.180.8.5548","article-title":"Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis","volume":"180","author":"Rawool","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.035_b0105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1128\/IAI.05511-11","article-title":"Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcgamma receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity","volume":"80","author":"Bitsaktsis","year":"2012","journal-title":"Infect Immunity"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2016.12.035_b0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.micpath.2012.07.006","article-title":"Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection","volume":"53","author":"Kubelkova","year":"2012","journal-title":"Microb Pathogenesis"},{"key":"10.1016\/j.vaccine.2016.12.035_b0115","doi-asserted-by":"crossref","unstructured":"Diebold SS. Activation of dendritic cells by toll-like receptors and C-type lectins. Handbook of experimental pharmacology, vol. 188; 2009. p. 3-30.","DOI":"10.1007\/978-3-540-71029-5_1"},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.035_b0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/jir.2013.0046","article-title":"Microbial activation of gut dendritic cells and the control of mucosal immunity","volume":"33","author":"Owen","year":"2013","journal-title":"J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2016.12.035_b0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv Drug Delivery Rev"},{"issue":"36","key":"10.1016\/j.vaccine.2016.12.035_b0130","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2015.07.022","article-title":"Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-structure, function and species differences","volume":"33","author":"Pabst","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.035_b0135","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/17425247.2014.931936","article-title":"Intranasal formulations: promising strategy to deliver vaccines","volume":"11","author":"Riese","year":"2014","journal-title":"Exp Opinion Drug Delivery"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.035_b0140","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4049\/jimmunol.163.3.1382","article-title":"Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node address in naive lymphocyte adhesion to high endothelial venules in a mucosal site","volume":"163","author":"Csencsits","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.035_b0145","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/IAI.01412-07","article-title":"Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells","volume":"76","author":"Woolard","year":"2008","journal-title":"Infect Immunity"},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.035_b0150","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1054\/bjoc.2001.1801","article-title":"Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens","volume":"84","author":"Okada","year":"2001","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.vaccine.2016.12.035_b0155","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1084\/jem.20021348","article-title":"Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control","volume":"198","author":"Mullins","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.12.035_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4615-0559-4_12","article-title":"Intestinal absorption of colostral lymphoid cells in newborn animals","volume":"503","author":"Tuboly","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2016.12.035_b0165","first-page":"205","article-title":"Transfer of maternal leukocytes to the infant by human milk","volume":"222","author":"Goldman","year":"1997","journal-title":"Curr Topics Microbiol Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T16:12:52Z","timestamp":1692634372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X16312609"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}